A framework for assessing the risk of resistance for antimalarials in development

A framework for assessing the risk of resistance for antimalarials in development

Show other versions (1)

Bibliographic Details
Main Authors:	Ding Xavier C, Ubben David, Wells Timothy NC
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	Malaria Journal

Similar Items

A framework for assessing the risk of resistance for anti-malarials in development
by: Ding Xavier C, et al.
Published: (2012-08-01)

In vivo assessments to detect antimalarial resistance
by: Dhorda, M, et al.
Published: (2019)

Antimalarial drug resistance.
by: White, N
Published: (2004)

Antimalarial drug resistance
by: White, N
Published: (2004)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
by: Barnes, K, et al.
Published: (2005)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
by: Price, R, et al.
Published: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
by: Price, R, et al.
Published: (2007)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
by: Ringwald Pascal, et al.
Published: (2007-09-01)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
by: Olliaro Piero, et al.
Published: (2007-09-01)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
by: Shibeshi MA, et al.
Published: (2020-11-01)

The threat of antimalarial drug resistance
by: Hanboonkunupakarn, B, et al.
Published: (2016)

Resistance to Antimalarial Monotherapy Is Cyclic
by: Rachel Weitzman, et al.
Published: (2022-01-01)

A database of antimalarial drug resistance
by: Ringwald Pascal, et al.
Published: (2006-06-01)

Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
by: Prapaporn Chaniad, et al.
Published: (2023-01-01)

Does antimalarial mass drug administration increase or decrease the risk of resistance?
by: White, N
Published: (2016)

The global challenge of antimalarial drug resistance
by: Ringwald Pascal, et al.
Published: (2012-10-01)

Antimalarial drug resistance: the pace quickens.
by: White, N
Published: (1992)

Antimalarial dosing regimens and drug resistance.
by: Barnes, K, et al.
Published: (2008)

Bibliometric analysis of antimalarial drug resistance
by: Jialu Zhang, et al.
Published: (2024-02-01)

The assessment of antimalarial drug efficacy.
by: White, N
Published: (2002)

Monitoring antimalarial resistance: launching a cooperative effort.
by: Sibley, C, et al.
Published: (2010)

Monitoring antimalarial resistance: Launching a cooperative effort
by: Sibley, C, et al.
Published: (2010)

Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).
by: Lourens, C, et al.
Published: (2014)

Esterase mutation is a mechanism of resistance to antimalarial compounds
by: Eva S. Istvan, et al.
Published: (2017-01-01)

Novel antimalarial targets and the antimalarial pipeline
by: K. Chibale
Published: (2014-04-01)

Molecular assays for antimalarial drug resistance surveillance: A target product profile.
by: Christian Nsanzabana, et al.
Published: (2018-01-01)

Acridine-Based Antimalarials—From the Very First Synthetic Antimalarial to Recent Developments
by: Mélanie Fonte, et al.
Published: (2021-01-01)

Global resistance surveillance: ensuring antimalarial efficacy in the future.
by: Guerin, P, et al.
Published: (2009)

Delaying antimalarial drug resistance with combination chemotherapy.
by: White, N
Published: (1999)

Preventing antimalarial drug resistance through combinations.
by: White, N
Published: (1998)

Clinical status and implications of antimalarial drug resistance.
by: Winstanley, P, et al.
Published: (2002)

To beat resistance to antimalarials switch to combination medicines

The assessment of antimalarial drug efficacy in vivo
by: White, NJ
Published: (2022)

New antimalarials. A risk-benefit analysis.
by: Nosten, F, et al.
Published: (1995)

Antimalarial drug resistance: a threat to malaria elimination
by: Menard, D, et al.
Published: (2017)

Barcoding Genetically Distinct Plasmodium falciparum Strains for Comparative Assessment of Fitness and Antimalarial Drug Resistance
by: Manuela Carrasquilla, et al.
Published: (2022-10-01)

Data on selected antimalarial drug resistance markers in Zambia
by: Lungowe Sitali, et al.
Published: (2021-02-01)

Molecular assays for antimalarial drug resistance surveillance: a target product profile
by: Nsanzabana, C, et al.
Published: (2018)

Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
by: David C Warhurst, et al.
Published: (2016-01-01)

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: A WorldWide Antimalarial Resistance Network individual participant data meta-analysis
by: Price, R
Published: (2019)